Skip to main content
NIH funding notice RFA-AG-23-009

Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)

Closed on June 14, 2022.

Posted
December 28, 2021
Close date
June 14, 2022
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

Read the notice on Grants.gov · NIH Guide page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $8,558,452 in first-year total cost, median $662,522.

Most frequent study sections

  1. Special Emphasis Panel[ZAG1 (J1)]11
  2. ZAG1-ZIJ-5(J1)3

Most frequent institutions

  1. UNIVERSITY OF MARYLAND BALTIMORE2
  2. DUKE UNIVERSITY1
  3. ENDEAVOR HEALTH CLINICAL OPERATIONS1
  4. ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI1
  5. MASSACHUSETTS INSTITUTE OF TECHNOLOGY1
Competing awards under RFA-AG-23-009 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
2023Investigating cell-type specific convergence of APOE and ABCA7 lipid dysregulation in Alzheimer’s disease1R56AG081376-01KELLIS, MANOLISTSAI, LI-HUEIMASSACHUSETTS INSTITUTE OF TECHNOLOGY, MA$753,667ZAG1
2023Investigating the effects of APOE and APOE-related AD risk genes on human microglia activity and lipid metabolism in aging and disease1R56AG081417-01MARCORA, EDOARDOICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, NY$745,765ZAG1
2023Metabolic age to define influences of the lipidome on brain aging in Alzheimer's disease1R01AG081322-01ARNOLD, MATTHIASKADDURAH-DAOUK, RIMA FMEIKLE, PETER JOHNDUKE UNIVERSITY, NC$725,129ZAG1
2023Neuronal Vulnerability to Lipid Droplets and Cholesterol in Alzheimer's Disease1R01AG081374-01DUAN, JUBAOENDEAVOR HEALTH CLINICAL OPERATIONS, IL$691,408ZAG1
2023Endolysosomal trafficking and lipid metabolism defects in FTLD1R01AG081452-01HUANG, ERIC JUNIVERSITY OF CALIFORNIA, SAN FRANCISCO, CA$670,577ZAG1
2023Brain lipids and AD1R01AG081375-01ZHAO, JINYINGUNIVERSITY OF FLORIDA, FL$670,464ZAG1
2023Impact of Mitochondrial Lipidomic Dynamics and its Interaction with APOE Isoforms on Brain Aging and Alzheimers Disease1R01AG081426-01LI, DANNILI, LINGUNIVERSITY OF MINNESOTA, MN$664,641ZAG1
2023Regulation of LDAM by autopahgy in the aging brain1R56AG081262-01LIPINSKI, MARTA MUNIVERSITY OF MARYLAND BALTIMORE, MD$660,402ZAG1
2023Role of GlcSph in cognitive deficits in Lewy body dementias1R01AG081433-01VOLPICELLI-DALEY, LAURA A.UNIVERSITY OF ALABAMA AT BIRMINGHAM, AL$630,971ZAG1
2023Defining lipid droplet homeostasis in Alzheimer's disease and aging with high molecular specificity using mass spectrometry imaging and isomer resolved lipidomics1R01AG081436-01SCOTT, ALISON JUNIVERSITY OF MARYLAND BALTIMORE, MD$599,632ZAG1
2023Assessing the role of APOE in glial lipid droplet metabolism and function1R01AG081421-01COHEN, SARAHJOHNSON, LANCE ALLENUNIV OF NORTH CAROLINA CHAPEL HILL, NC$585,570ZAG1
2023Role of the microglial immune-oxysterol 25-hydroxycholesterol in mediating neuroinflammation and neurodegeneration in the P301S tau transgenic mouse model of Alzheimer's disease1R01AG081419-01CASHIKAR, ANIL GWASHINGTON UNIVERSITY, MO$477,725ZAG1
2023Role of TTYH1 in mobilizing lipids and ApoE in glia: Implications for brain aging and neurodegeneration1R01AG081379-01WONG, CHING-ONRUTGERS THE STATE UNIV OF NJ NEWARK, NJ$343,438ZAG1
2023Cardiolipin Remodeling in Alzheimer’s Disease1R01AG081422-01SHI, YUGUANGUNIVERSITY OF TEXAS HLTH SCIENCE CENTER, TX$339,063ZAG1

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-10-0.1.1. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for faculty

Your academic CV and NIH biosketch

Make your CV in your school's format and your NIH biosketch from it, then download both as Word files.

RFA-AG-23-009: Lipids in Brain Aging and Alzheimer's Disease (AD) and its Related Dementias (ADRD) (R01 Clinical Trial Not Allowed) | ScienceDex | ConductScience